R. Nanda

1Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL

Papers on Lattice

Total citations

Topics

h-index

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Y. Chen (1)Y. Abdou (1)N. Jahan (1)E. Mayer (1)

Papers (1)

Feb 17, 2026

3w ago·also Corcept Therapeutics, Dana Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Pfizer/Astellas +4

Abstract PS5-09-04: Tbcrc 058: a randomized phase 2 study of enzalutamide, enzalutamide with mifepristone, and treatment of physician’s choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (nct06099769)

This study will determine if enzalutamide, with or without mifepristone, improves progression-free survival compared to standard chemotherapy in patients with AR+ metastatic triple-negative or estrogen receptor-low breast cancer.

R. Nanda, Y. Chen, Y. Abdou +13

Search

R. Nanda

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Papers (1)